Skip to Content
Print Save

RDY 453 (Venlafaxine Hydrochloride Extended Release 37.5 mg)

Pill with imprint RDY 453 is Gray & Pink, Capsule-shape and has been identified as Venlafaxine Hydrochloride Extended Release 37.5 mg. It is supplied by Dr. Reddy's Laboratories Ltd..

Venlafaxine is used in the treatment of autism; anxiety; major depressive disorder; depression; generalized anxiety disorder and belongs to the drug class serotonin-norepinephrine reuptake inhibitors. Risk cannot be ruled out during pregnancy. Venlafaxine 37.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for RDY 453

Venlafaxine Hydrochloride Extended Release

Imprint
RDY 453
Strength
37.5 mg
Color
Gray & Pink
Size
16.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Serotonin-norepinephrine reuptake inhibitors
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Dr. Reddy's Laboratories Ltd.
National Drug Code (NDC)
55111-0453
Inactive Ingredients
dimethylaminoethyl methacrylate - butyl methacrylate - methyl methacrylate copolymer, ethylcelluloses, gelatin, medium-chain triglycerides, microcrystalline cellulose, povidone, ferric oxide red, sodium stearyl fumarate, magnesium silicate, titanium dioxide, ferrosoferric oxide, ferric oxide yellow, potassium hydroxide, propylene glycol, shellac, ammonia

Note: Inactive ingredients may vary.

More Info Imprint Search Print

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer